News
The Chicago Human Rhythm Project is celebrating 35 years of rhythm, culture and community with Rhythm World, a weeklong ...
The next program of the Rhythm on the River Arts Series in Grand Rapids will be presented by Lake Effect Clarinet Quartet on ...
Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.
The Winthrop Rhythm & Blues Festival will bring musical talent from all over the globe — and from our own backyard — when it ...
1d
Zacks Investment Research on MSNRYTM Stock Rises on Upbeat Acquired Hypothalamic Obesity Study DataShares of Rhythm Pharmaceuticals RYTM were up 36.6% yesterday after it reported positive top-line data from a phase II study ...
Rhythm Pharmaceuticals (RYTM) witnessed a jump in share price last session on above-average trading volume. The latest trend ...
Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM) (“Rhythm”), a global, commercial-stage biopharmaceutical company dedicated to ...
Rhythm's bivamelagon cut BMI and hunger scores in Phase 2 trial for hypothalamic obesity, prompting plans to discuss Phase 3 ...
Merck & Co. Inc. has strengthened its cardiopulmonary pipeline with its $10 billion acquisition of London-based-Verona Pharma plc. The deal brings Merck Ohtuvayre (ensifentrine) for chronic ...
2d
Stocktwits on MSNRhythm Pharma Shares Soar After Experimental Drug Yields Weight Reduction In Brain-Damage Related ObesityRhythm Pharmaceuticals, Inc. (RYTM) on Wednesday announced that its drug Bivamelagon achieved statistically significant and ...
Shares of US biopharma Rhythm Pharmaceuticals rose 27.4% to $82.96 in early trading today, as it announced positive top-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results